Health

Diabetes drug increases heart attack risk: report

AFP
Thursday, September 13, 2007

WASHINGTON -- An analysis of four clinical trials involving more than 14,000 patients found that dia

betes medication Avandia (rosiglitazone) taken over a lengthy period of time increases the risk of heart attack by 42 percent, a report released Tuesday said.

It marks one of the first studies to look at how use for one year or longer of Avandia, in patients with type 2 diabetes, affects risk of heart attack, heart failure and mortality, according to authors of the study in the September 12 issue of the Journal of The American Medical Association (JAMA).

Most Viewed 24 hrs Week Month

	1		Reforms welcome foreign capital
	2		Chen's son goes missing
	3		Ou to Singapore: Thanks for help
	4		Britain's 100-year record for medals, China still lead
	5		Verdict on libel suit against Chen set for September 9
	6		China returns confiscated Bibles to U.S. Christian group as they leave the country
	7		Former president's diehard supporter revokes name change
	8		MOJ examines prosecutor's actions in Chen scandal
	9		Russians take Georgians prisoner in Black Sea port
	10		Malaysia arrests 2 state lawmakers from Anwar's party for alleged graft ahead of by-election

Health

Next:

Pay obese to lose weight, Australian doctors urge

▪	Pay obese to lose weight, Australian doctors urge
▪	Breastfeeding has no impact on asthma risk, says study
▪	Contraceptive pill may cut cancer risk: study
▪	To lose is to win on U.S. TV's 'Biggest Loser' reality show

more Health >>

Diabetes drug increases heart attack risk: report

AFPThursday, September 13, 2007

AFP
Thursday, September 13, 2007